Table 3.

Clinical characteristics of subjects by timing of computed tomography examination

		After starting treatment
	At diagnosis	Less than 1 year	1 year or more
Variables	n = 36	n = 42	n = 60
Age, median (IQR)	2.5 (2–5.75)	3 (2–6.25)	5 (4–9.75)
Girl, n (%)	23 (63.9%)	26 (61.9%)	43 (71.7%)
HT-z, mean (SD)	− 0.25 (0.99)	− 0.66 (0.87)	− 1.26 (1.04)
BW-z, mean (SD)	− 0.31 (1.21)	− 0.72 (1.20)	− 1.14 (1.36)
BMI-z, mean (SD)	− 0.20 (1.33)	− 0.40 (1.40)	− 0.43 (1.12)
SMI-z, mean (SD)	− 0.66 (1.07)	− 0.42 (1.09)	− 1.12 (1.03)
INRG high-risk, n (%)	25 (69.4%)	32 (76.2%)	54 (90.0%)

IQR interquartile range, HT-z z-score for body height, BW-z z-score for body weight, BMI-z z-score for body mass index, SMI-z z-score for skeletal muscle index, INRG International Neuroblastoma Risk Group, SD standard deviation